Long-Term Levothyroxine Use May Reduce CV Risk In Older Adults

from TheBrief.Health · host TheBrief.Health

Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.

Episode metadata supplied by the publisher feed · Published Mar 9, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Long-Term Levothyroxine Use May Reduce CV Risk In Older Adults

0:00 1:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

A Growing Movement Aims to Prepare All Physicians to Care for Older Adults

Apr 15, 2026 ·12m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on March 9, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!